Page results
-
Neurosurgery is a treatment option for some people with epilepsy.
-
UCLH is supporting a new UK-wide health and care research registry, as part of the nation’s biggest-ever recruitment drive to clinical trials.
-
Advice on sleeping better for young people living with fatigue conditions.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Information for patients and visitors on patient isolation.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
File results
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care
-
FOI/2022/0233 - Diagnosis/ treatment of epilepsy, dravet syndrome, lennox gastaut syndrome and tuberous sclerosis complex
-
FOI/2022/0236 - Video communication software licences
-
FOI/2022/0238 - Number of mobile devices at Trust
-
FOI/2022/0244 - Craniocervical Instability assessment/ treatment
-
FOI/2022/0246 - Adult haematology services
-
FOI/2022/0247 - Care Axial SpA referrals to rheumatology
-
FOI/2022/0249 - Robotic process automation/ intelligent automation technology
-
FOI/2022/0250 - Number of staff employed and number of new patients diagnosed for breast, colorectal, head and neck and oesophageal cancer